Cataract surgery in patients taking alpha-1 antagonists: know the risks, avoid the complications
- PMID: 22690253
- PMCID: PMC3371631
- DOI: 10.3238/arztebl.2012.0379
Cataract surgery in patients taking alpha-1 antagonists: know the risks, avoid the complications
Abstract
Background: The growing use of alpha-1 receptor antagonists in the treatment of benign prostatic hyperplasia (BPH) has created a new problem in ophthalmic surgery, the so-called intraoperative floppy iris syndrome (IFIS). This consists of a billowing iris, insufficient pupillary dilation with progressive intraoperative miosis, and protrusion of iris tissue through the tunnel and side port incision that are made for access to the anterior chamber during surgery. IFIS presents particular difficulties in cataract surgery which is carried out through the pupil with manipulations in the immediate vicinity of the iris. The complications range from poor visibility of the operative field to iris damage with the surgical instruments and to rupture of the posterior capsule, with loss of lens material into the vitreous body.
Methods: Selective literature review.
Results: Alpha-blockers have a direct effect on the alpha-receptors of the iris but also induce ultrastructural changes in the iridial stroma, leading to IFIS. The most important factor in avoiding complications of IFIS seems to be the ophthalmic surgeon's knowledge that the patient is taking an alpha-1 receptor antagonist.
Conclusion: A thorough medical history and an optimized information flow among all physicians treating the patient-the urologist, the family physician, and the ophthalmic surgeon-are essential for safe cataract surgery.
Figures
References
-
- Deutsche Gesellschaft für Urologie (DGU). Leitlinien der Deutschen Gesellschaft für Urologie (DGU) und des Berufsverbands der Deutschen Urologen (BDU) Therapie des Benignen Prostatasyndroms (BPS) www.awmf.org/uploads/tx_szleitlinien/043-035l_S2e_Benignes_Prostatasyndr.... - PubMed
-
- Kortmann BB, Floratos DL, Kiemeney LA, Wijkstra H, de la Rosette JJ. Urodynamic effects of alpha-adrenoceptor blockers: a review of clinical trials. Urology. 2003;62:1–9. - PubMed
-
- Roehrborn CG, Schwinn DA. Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia. J Urol. 2004;171:1029–1035. - PubMed
-
- Oelke M, Bachmann A, Descazeaud A, et al. Guidelines on the treatment of non-neurogenic male LUTS. European Association of Urology. 2011
-
- Sterrett SP, Nakada SY. Medical expulsive therapy. Curr Opin Urol. 2008;18:210–213. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
